Nature Biotechnology
22, 1591 - 1592 (2004)
doi:10.1038/nbt1204-1591
Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivityTamar Morag-Sela1, Ilan Cohn1, Thomas J Kowalski2, Judy Jarecki-Black3
& Zoe Clyde-Watson41
Tamar Morag-Sela and Ilan Cohn are at Reinhold Cohn and Partners, PO Box 4060, Tel Aviv 61040, Israel
or Thomas J. Kowalski is at Frommer Lawrence & Haug LLP, 745 Fifth Avenue, New York, New York10151, USAtkowalski@flhlaw.com3
Judy Jarecki-Black is at Merial Ltd., 3239 Satellite Blvd., Duluth, Georgia 30096-4640, USA
4
Zoe Clyde-Watson is at D. Young & Co., 120 Holborn, London EC1N 2DY, UK. Can Israel balance the rights of multinational drug companies with its own generic pharmaceutical industry?
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Material witness: Patent pending
Nature Materials News and Views (01 Jun 2003)
|
|